3Taki H, Maki T, Iso T, et al. Postmarketing study Ornate-glinide in Japan:treatment of medication-naive patients with type -diabetes[J]. Adv Ther,2005,22(6) :621 - 635.
4Yin J, Yang G,Cben Y. Rapid and efficient chiral separation of nateglinide arid its L-enantiomer on monolithic molecularly imprinted polymers[J]. J Chromatogr A, 2005,1090 ( 1 ) : 68- 75.
5Gerieh J, Raskin P,Jcan- Louis L, et al. PRESERVE- beta: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin[J]. Diabetes Care,2005,28(9):2 093-2 099.
6Kentrup H, Bangers H, et al. Efficacy and safe- ty of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr, 1999,158(6) :455 -459.
7American Diabetes Association. Summary of Revisions for the 2007 Clinical Practice Rec- ommendations Standards of Medical Care in Diabetes. Diabetes Care,2007,30 : s3 - s40.
